Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 14/20 | 0.65 |
| ▸ | MME | P08473 | 11/20 | 0.65 |
| ▸ | CPA1 | P15085 | 6/20 | 0.65 |
| ▸ | ACE2 | Q9BYF1 | 6/20 | 0.65 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31223212 | 0.96 | ACE (0.60) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL31223213 | 0.96 | ACE (0.60) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL29822555 | 0.94 | ACE (0.70) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL31202567 | 0.94 | ACE (0.73) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL4261778 | 0.94 | ACE (0.73) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL4261774 | 0.94 | ACE (0.73) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL29669675 | 0.94 | ACE (0.73) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL7685718 | 0.94 | ACE (0.73) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL30411231 | 0.94 | ACE (0.73) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL7128864 | 0.94 | ACE (0.73) | ACEMMECPA1ACE2FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240167070-A1 | METHODS FOR CYCLIZATION OF (POLY)PEPTIDES COMPRISING Ny-HYDROXY- OR Ny-AMINO-L-ASPARAGINE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240167070-A1 | METHODS FOR CYCLIZATION OF (POLY)PEPTIDES COMPRISING Ny-HYDROXY- OR Ny-AMINO-L-ASPARAGINE | ANPEP, DNPEP, ASNS | ACE 614/4885MME 225/4885CPA1 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.